Ledger.Open graph →
SEC Form D · Amendment · filed May 2, 2024

Lucy Therapeutics, Inc

Offering
$10.6M
Sold
$10.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Rachel Sha · Waltham, MADirectorAmy Ripka · Waltham, MAExec · DirectorJohn Ripple · Waltham, MADirectorRachel Sha · Waltham, MADirectorJohn Ripple · Waltham, MADirectorAmy Ripka · Waltham, MAExec · DirectorRobert M. Poole · Waltham, MADirectorGregory Poapst · Miami Springs, FLDirectorChristopher Lawler · San Francisco, CADirectorChristopher Collins · San Francisco, CAExec · DirectorRobert M. Poole · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗